In one paragraphArticle in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
15 authors.
Esra AsarkayaDepartment of Medical Oncology, Cukurova University Faculty of Medicine, 01330 Adana, Türkiye.
Hatice AsogluDepartment of Medical Oncology, Cukurova University Faculty of Medicine, 01330 Adana, Türkiye.ORCID 0009-0000-1366-5552 Abdurrahman AykutDepartment of Medical Oncology, Cukurova University Faculty of Medicine, 01330 Adana, Türkiye.ORCID 0000-0002-2671-9393 Gunes Dorukhan CavusogluDepartment of Medical Oncology, Cukurova University Faculty of Medicine, 01330 Adana, Türkiye.ORCID 0000-0001-8914-7911 Yasemin AydınalpDepartment of Medical Oncology, Sanlıurfa Mehmet Akif İnan Training and Research Hospital, 63300 Şanlıurfa, Türkiye.ORCID 0000-0003-2435-368X Sendag YaslıkayaDepartment of Medical Oncology, Giresun Training and Research Hospital, 28100 Giresun, Türkiye.ORCID 0000-0001-5264-8405 Suheda Atas IpekDepartment of Medical Oncology, Cukurova University Faculty of Medicine, 01330 Adana, Türkiye.ORCID 0000-0003-1377-0488 Fatma CalkanDepartment of Pathology, Cukurova University Faculty of Medicine, 01330 Adana, Türkiye.
Emine Kilic BagirDepartment of Pathology, Cukurova University Faculty of Medicine, 01330 Adana, Türkiye.ORCID 0000-0002-1447-1060 Derya GumurduluDepartment of Pathology, Cukurova University Faculty of Medicine, 01330 Adana, Türkiye.ORCID 0000-0002-7129-3424 Hulya BinokayDepartment of Biostatistics, Cukurova University Faculty of Medicine, 01330 Adana, Türkiye.
Tolga KoseciDepartment of Medical Oncology, Cukurova University Faculty of Medicine, 01330 Adana, Türkiye.
Ismail Oguz KaraDepartment of Medical Oncology, Cukurova University Faculty of Medicine, 01330 Adana, Türkiye.
Berksoy SahinDepartment of Medical Oncology, Cukurova University Faculty of Medicine, 01330 Adana, Türkiye.
Ertugrul BayramDepartment of Medical Oncology, Cukurova University Faculty of Medicine, 01330 Adana, Türkiye.ORCID 0000-0001-8713-7613 Funding
Turkish Society of Medical Oncology
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
EZH2immune checkpoint inhibitorsNSCLC
Identifiers
PMID42739617
PMCPMC13565942
What OpenQuestion holds
Textmetadata
Read underepoch 390